![Anders Nykjaer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anders Nykjaer
Fondateur chez
Insusense ApS
Profil
Anders Nykjaer is the founder.
Founded Recepticon ApS in 2001, held the title of Co-Chief Scientific Officer from 2009 to 2010.
Dr. Nykjaer is also the founder of Insusense ApS.
Current job at the University of Aarhus as a Professor.
Former job at Lundbeckfonden as Co-Chairman.
Education includes a doctorate from the University of Aarhus, conferred in 1995, and another doctorate from the University of Aarhus, conferred in 1991.
Postes actifs de Anders Nykjaer
| Sociétés | Poste | Début |
|---|---|---|
University of Aarhus
 University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Insusense ApS
 Insusense ApS BiotechnologyHealth Technology Provides research and development in biotechnology | Fondateur | - |
Anciens postes connus de Anders Nykjaer
| Sociétés | Poste | Fin |
|---|---|---|
Recepticon ApS
 Recepticon ApS Pharmaceuticals: MajorHealth Technology Develops receptor antagonists for prevention of medical induced organ damage | Fondateur | 23/03/2010 |
Lundbeckfonden
 Lundbeckfonden Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Président | - |
Formation de Anders Nykjaer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Lundbeckfonden
Lundbeckfonden Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
University of Aarhus
University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Recepticon ApS
Recepticon ApS Pharmaceuticals: MajorHealth Technology Develops receptor antagonists for prevention of medical induced organ damage | Health Technology |
Insusense ApS
Insusense ApS BiotechnologyHealth Technology Provides research and development in biotechnology | Health Technology |
